Midgard Science

Labs / Assays & in vitro testing

Ainnocence

Mountain View, CA, United States · ainnocence.com

GLP

Ainnocence is a biotech company that uses AI and wet-lab validation to design antibodies, small molecules, peptides, cell therapies, natural products, and RNA therapeutics. It works with pharma partners on target-specific discovery programs from sequence data, with offices in the Bay Area. The company says it provides validated, licensable candidates and freedom-to-operate analysis.

They take quote requests by email.

What they offer

  • SentinusAI

    Antibody design and protein engineering, including de novo antibody design, affinity maturation, bispecific and multispecific engineering, and format conversion.

  • CarbonAI

    De novo small-molecule generation, PROTAC design, scaffold hopping, and CRBN neosubstrate selectivity panel design.

  • CellulaAI

    CAR construct optimization and modeling for CAR-T, allogeneic cell therapies, and gene-edited cellular products.

  • PeptideAI

    Design of peptide therapeutics, including cyclic, stapled, and GLP-1 analogs, with sequence optimization.

  • NatmolAI

    Computational expansion and optimization of natural-product chemical space, including scaffold library mining and semi-synthetic analog generation.

  • SenseAI

    Design of RNA therapeutics, including mRNA, siRNA, and ASOs, with sequence-based optimization.

  • Custom target engagements

    Partnering service in which the company assembles the needed platforms for a target and delivers wet-lab-validated candidates with freedom-to-operate analysis.

What they work on

Modalities
Small molecule, Antibody, Bispecific, Peptide, Oligonucleotide, mRNA, Cell therapy
Species and models
IgG, Fab, scFv, VHH, bispecifics, CRBN neosubstrate panels
Assays and studies
affinity prediction, generative design, virtual screening, wet-lab validation, activation prediction, persistence modeling, secondary structure prediction, stability modeling, efficacy ranking, selectivity panels
Scale and capacity
167M-parameter protein foundation model (AINN-P1), screen up to 10 billion protein sequences or chemical compounds within hours, 1M+ antibody variants evaluated, 10^10 compounds overnight, 3.2M peptide screens, 40 validated targets, 2,872 molecules experimentally tested in wet lab
Therapeutic areas
drug discovery, precision medicine, oncology
Turnaround
overnight · typically in weeks, not quarters · within a week
What to send
Bring us a target · Pick a target you care about
Sites
Bay Area, USA
Quality
wet-lab validated · patentable IP · freedom-to-operate analysis
Address
3 Tn Ln;x 7x묊btfzk q¾L 9N~֫c3\q7ߠMjh'
Founded
2021

Similar labs. Olympic Protein Technologies, Akeagen, Aurigene Pharmaceutical Services, Evotec

Found in a contract services directory. Listing built from ainnocence.com. Work here? Claim this listing.

Ainnocence · Midgard Science